August 2023 - Page 2 of 3 - PsychedelicNewsWire (PNW)

ThursdayAug 17, 2023 2:40 pm

New Study Says Psychedelics Use, Mindfulness Meditation Trigger Leadership Improvements

A new study published in the journal “Frontiers in Psychology” suggests that psychedelic use and mindfulness meditation may trigger leadership improvements and result in positive leadership outcomes. The preliminary study joins a growing body of scientific literature on the impact of psychedelic use on various facets of mental health. Prior research has found that psychedelics may be effective at treating a myriad of severe mental health conditions at minimal doses and with barely any adverse side effects. Researchers have been particularly interested in how psychedelics affect the brain and whether they could leverage these effects to treat anything from anxiety…

WednesdayAug 16, 2023 3:42 pm

BrainFutures, APPA Publish First-Ever Guidelines for Professional Psychedelics Therapists

The American Psychedelic Practitioners Association (APPA) and nonprofit BrainFutures have teamed up to publish the first-ever guidelines for psychedelic-assisted therapists. These new guidelines will establish standards for the relatively new field of psychedelic-assisted therapy as the segment matures amid positive legislative changes and increasing research. A working group of professional experts from different disciplines in the nascent psychedelic field created the guidelines with the aim of educating and guiding therapy practitioners before psychedelic-assisted therapy models start being used outside of research and clinical trials. Psychedelic-assisted therapy presents an exciting new paradigm in psychiatry because it has the potential to deliver…

TuesdayAug 15, 2023 3:16 pm

Planned Clinical Trial to Explore Psychedelics for Gambling Addiction Treatment

Researchers from the Imperial College London’s Center for Psychedelic Research have announced plans to carry out a clinical trial exploring the potential of psychedelics as gambling addiction treatments. After recently studying psychedelics-assisted therapies in treating depression, the center is now looking to investigate whether psilocybin has therapeutic potential against addictions such as gambling. It will be the first study exploring psychedelics as treatments for addiction and is slated to begin in October 2023 with five participants and a control group. According to the study’s recruitment page, the study’s main aim is to determine how gambling-related activities affect the brain’s reward…

MondayAug 14, 2023 3:00 pm

Preliminary Trial Shows Psilocybin Reduces Intensity, Magnitude of Migraines

A preliminary study has revealed that psilocybin, the main psychoactive agent in magic mushrooms, may have applications in migraine treatments. Researchers from Yale School of Medicine recently ran the first-ever clinical trial on the therapeutic potential of psychedelics against migraines. Led by Dr. Emmanuelle Schindler, the research team determined that psilocybin could reduce the number of weekly migraine days by one-half in people with chronic migraines. Furthermore, the researchers determined that even a single dose of the psychedelic could reduce the intensity of migraine attacks by a significant degree in only two weeks with no adverse side effects. Although prior…

FridayAug 11, 2023 3:27 pm

Study Says Psychedelics Trigger Rats’ Brain Waves to Form in Sync

Lund University researchers have come up with a technique that allows them to simultaneously measure electrical signals from 128 different areas of a rat’s brain. Using this groundbreaking technique, the researchers studied different regions of rats’ brains after they took psychedelics to analyze how hallucinogenic drugs affected their neurons. Interestingly, the team found that psychedelics caused brain waves in different regions of the brain to form simultaneously and in sync in rats that were awake. This study was working off the findings of prior research on the impact of electrical oscillations within the brain on rats with Parkinson’s disease. Led…

ThursdayAug 10, 2023 2:13 pm

Senate Committee Says Schedule 1 Classification Hindering Psychedelic Research

A recent spending bill report from a major Senate committee has acknowledged that federal prohibition is hindering comprehensive research into psychedelics. Sections within the report encourage federally sponsored studies involving psychedelics and marijuana but note that the two drugs’ federal status as Schedule I drugs presents a significant barrier to research. The comments were part of a report on a spending bill that provides funding for several key agencies for fiscal year 2024. Psychedelic research may be a relatively new field, but it has attracted considerable attention from lawmakers and the general public due to its potentially game-changing findings. Studies…

WednesdayAug 09, 2023 1:52 pm

Animal Study Shows Psilocybin Fix Cognitive Deficits Resulting from Stress-Related Depression

A recent study published in the “Psychedelic Medicine” journal has reported that psilocybin possesses effects akin to antidepressants and may alleviate cognitive deficits resulting from chronic stress in animal models. Psilocybin is a hallucinogenic compound produced in magic mushrooms. Although it has been used recreationally for decades because of its hallucinatory effects, a growing body of research now shows that psilocybin may also have a myriad of mental health benefits. This research has found that psilocybin as well as other psychedelic compounds such as LSD and ayahuasca can treat various mental-health conditions, offering relatively long-term relief at low doses and…

TuesdayAug 08, 2023 12:10 pm

Study Compares Human Brains During Meditation, Hypnosis, Under Psychedelics

Researchers from the University of Zurich Psychiatric Hospital are comparing what happens to the human brain during meditation and hypnosis, as well as while under the effects of psychedelics. Brain changes while under the influence of drugs or during states such as hypnosis and meditation have been an object of interest for researchers for quite a while now. Now that psychedelics have emerged as potential mental health treatments with much higher success rates and fewer side effects, researchers are even more interested in how drugs like psychedelics cause changes in the brain. University of Zurich researchers were particularly interested in…

MondayAug 07, 2023 3:29 pm

California Ballot Measure Seeks to Create Psychedelics Research Agency

A California-based physician has filed a ballot measure that would invest $5 billion into researching the potential benefits of using psychedelics to treat specific mental disorders. The proposed bond initiative would use billions of dollars in state funds to support the study of psychedelics such as psilocybin, ketamine and LSD as potential mental health treatments. Last month, Los Angeles-based internal medicine physician Dr. Jeannie Fontana filed paperwork to place the Treat California Initiative on the November ballot. The measure would also call for the creation of a new agency to study the impact of psychedelic-assisted therapy on people with mental…

FridayAug 04, 2023 12:01 pm

Study Sheds Light on How Psychedelics Affect Social Cognition, the DMN, and ToM

Research into psychedelics has revealed that the Default Mode Network (DMN), a series of interconnected regions in the brain that are involved in introspection, may play a role in how psychedelics deliver their effects. The DMN is associated with self-criticism and self-reflection and exhibits amplified activity when people take part in tasks that require interacting with and understanding others. Conversely, prior research has found that an overactive Default Mode Network may also be associated with obsessive-compulsive disorder (OCD), anxiety and depression. On the other hand, the Theory of Mind (ToM) Network has been tied to perspective taking, the ability to…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Month: August 2023